HAZELNUT: Overview, Uses, Side Effects, Precautions, Interactions, Dosing and Reviews

Overview

Hazelnut is the nut from the hazel tree (Corylus avellana). It is rich in monounsaturated fatty acids and is commonly eaten as food.

Hazelnut contains oil, protein, fiber, and antioxidants. The antioxidants in hazelnut might have heart health benefits.

People use hazelnut for obesity, high cholesterol, heart disease, dementia, and other purposes, but there is no good scientific evidence to support these uses.

Hazelnut is a tree nut. It is considered a major food allergen.

Uses & Effectiveness

Possibly Ineffective for

Obesity. Eating hazelnuts or taking hazelnut oil by mouth doesn't seem to decrease body weight in people who are obese or overweight.

There is interest in using hazelnut for a number of other purposes, but there isn’t enough reliable information to say whether it might be helpful.

Side Effects

When taken by mouth: Hazelnut is commonly consumed in foods. It’s usually well-tolerated, but some people are allergic to hazelnuts. Serious allergic reactions are possible.

Special Precautions and Warnings

When taken by mouth: Hazelnut is commonly consumed in foods. It’s usually well-tolerated, but some people are allergic to hazelnuts. Serious allergic reactions are possible.

Pregnancy and breast-feeding: Hazelnut is commonly consumed in foods. There isn’t enough reliable information to know if hazelnut is safe to use as medicine while pregnant or breast-feeding. Stay on the safe side and stick to food amounts.

Allergies: People who are allergic to peanuts, cashews, walnuts, mugwort pollen, Brazil nut, birch pollen, or macadamia nut might also be allergic to hazelnut.

Interactions

We currently have no information for HAZELNUT overview.

Dosing

Hazelnut is commonly consumed in moderate amounts as part of the diet.

As medicine, there isn’t enough reliable information to know what an appropriate dose of hazelnut might be. Speak with a healthcare provider before use.

View References

REFERENCES:

Bonjour JP. Biotin in human nutrition. Ann N Y Acad Sci 1985;447:97-104. View abstract.

Bougnoux P, Hajjaji N, Ferrasson MN, Giraudeau B, Couet C, Le Floch O. Improving outcome of chemotherapy of metastatic breast cancer by docosahexaenoic acid: a phase II trial. Br J Cancer. 2009 Dec 15;101(12):1978-85. View abstract.

Braarud HC, Markhus MW, Skotheim S, et al. Maternal DHA status during pregnancy has a positive impact on infant problem solving: A Norwegian prospective observation study. Nutrients. 2018;10(5). pii: E529. View abstract.

Breastfeeding and the use of human milk. Section on Breastfeeding. Pediatrics. 2012;129(3):e827-41. View abstract.

Calder PC. N-3 polyunsaturated fatty acids, inflammation and immunity: pouring oil on troubled waters or another fishy tale? Nutr Res 2001;21:309-41.

Cao Y, Hou L, Wang W. Dietary total fat and fatty acids intake, serum fatty acids and risk of breast cancer: A meta-analysis of prospective cohort studies. Int J Cancer. 2016;138(8):1894-904. doi: 10.1002/ijc.29938. View abstract.

Carlson SE, Colombo J, Gajewski BJ, Gustafson KM, Mundy D, Yeast J, Georgieff MK, Markley LA, Kerling EH, Shaddy DJ. DHA supplementation and pregnancy outcomes. Am J Clin Nutr. 2013 Apr;97(4):808-15. View abstract.

Carlson SE, Gajewski BJ, Valentine CJ, et al. Early and late preterm birth rates in participants adherent to randomly assigned high dose docosahexaenoic acid (DHA) supplementation in pregnancy. Clin Nutr 2023;42(2):235-243. View abstract.

Carlson SE, Gajewski BJ, Valentine CJ, et al. Higher dose docosahexaenoic acid supplementation during pregnancy and early preterm birth: a randomised, double-blind, adaptive-design superiority trial. EClinicalMedicine. 2021;36:100905. View abstract.

Carlson SE, Werkman SH. A randomized trial of visual attention of preterm infants fed docosahexaenoic acid until two months. Lipids 1996;31:85-90. View abstract.

Carucci S, Romaniello R, Demuru G, et al. Omega-3/6 supplementation for mild to moderate inattentive ADHD: a randomised, double-blind, placebo-controlled efficacy study in Italian children. Eur Arch Psychiatry Clin Neurosci 2022;272(8):1453-1467. View abstract.

Chan SS, Luben R, Olsen A, Tjonneland A, Kaaks R, Lindgren S, Grip O, Bergmann MM, Boeing H, Hallmans G, Karling P, Overvad K, Venø SK, van Schaik F, Bueno-de-Mesquita B, Oldenburg B, Khaw KT, Riboli E, Hart AR. Association between high dietary intake of the n-3 polyunsaturated fatty acid docosahexaenoic acid and reduced risk of Crohn's disease. Aliment Pharmacol Ther. 2014 Apr;39(8):834-42. View abstract.

Cheruku SR, Montgomery-Downs HE, Farkas SL, et al. Higher maternal plasma docosahexaenoic acid during pregnancy is associated with more mature neonatal sleep-state patterning. Am J Clin Nutr 2002;76:608-13. View abstract.

Chew EY, Clemons TE, SanGiovanni JP, et al. Age-Related Eye Disease Study 2 Research Group. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA 2013;309(19):2005-2015. View abstract.

Cho E, Hung S, Willet W, et al. Prospective study of dietary fat and the risk of age-related macular degeneration. Am J Clin Nutr 2001;73:209-18.. View abstract.

Christifano DN, Crawford SA, Lee G, et al. Docosahexaenoic acid (DHA) intake estimated from a 7-question survey identifies pregnancies most likely to benefit from high-dose DHA supplementation. Clin Nutr ESPEN 2023;53:93-99. View abstract.

Christifano DN, Gustafson KM, Carlson SE, et al. Maternal docosahexaenoic acid exposure needed to achieve maternal-newborn EQ. Nutrients 2022;14(16):3300. View abstract.

Ciappolino V, DelVecchio G, Prunas C, et al. The effect of DHA supplementation on cognition in patients with bipolar disorder: An exploratory randomized control trial. Nutrients. 2020;12(3):708. View abstract.

Collins CT, Makrides M, Gibson RA, et al. Pre- and post-term growth in pre-term infants supplemented with higher-dose DHA: a randomized controlled trial. Br J Nutr 2011;105:1635-43. View abstract.

Collins CT, Makrides M, McPhee AJ, Sullivan TR, Davis PG, Thio M, et al. Docosahexaenoic acid and bronchopulmonary dysplasia in preterm infants. N Engl J Med. 2017 Mar 30;376(13):1245-1255. doi: 10.1056/NEJMoa1611942. View abstract.

Conquer JA, Holub BJ. Supplementation with an algae source of docosahexaenoic acid increases (n-3) fatty acid status and alters selected risk factors for heart disease in vegetarian subjects. J Nutr 1996;126:3032-9. View abstract.

Asero R. Detection and clinical characterization of patients with oral allergy syndrome caused by stable allergens in Rosaceae and nuts. Ann Allergy Asthma Immunol 1999;83:377-83. View abstract.

Bahaeddin Z, Yans A, Khodagholi F, Hajimehdipoor H, Sahranavard S. Hazelnut and neuroprotection: Improved memory and hindered anxiety in response to intra-hippocampal Aß injection. Nutr Neurosci. 2017 Jul;20(6):317-326.View abstract.

Caballero T, Martin-Esteban M. Association between pollen hypersensitivity and edible vegetable allergy: a review. J Investig Allergol Clin Immunol 1998;8:6-16. View abstract.

Caballero T, Pascual C, Garcia-Ara MC, Ojeda JA, Martin-Esteban M. IgE crossreactivity between mugwort pollen (Artemisia vulgaris) and hazelnut (Abellana nux) in sera from patients with sensitivity to both extracts. Clin Exp Allergy 1997;27:1203-11. View abstract.

FDA. Qualified Health Claims: Letter of Enforcement Discretion - Nuts and Coronary Heart Disease (Docket No 02P-0505). July 2003. Available at: https://wayback.archive-it.org/7993/20171114183724/https://www.fda.gov/Food/IngredientsPackagingLabeling/LabelingNutrition/ucm072926.htm. Accessed on March 6, 2020.

Feldman EB. The scientific evidence for a beneficial health relationship between walnuts and coronary heart disease. J Nutr 2002;132:1062S-101S. View abstract.

Food and Drug Administration. Food Allergen Labeling and Consumer Protection Act of 2004 (FALCPA); Public Law 108-282, Title II. Accessed on May 19, 2021. Available at: https://www.fda.gov/food/food-allergensgluten-free-guidance-documents-regulatory-information/food-allergen-labeling-and-consumer-protection-act-2004-falcpa.

Hu FB, Stampfer MJ. Nut consumption and risk of coronary heart disease: a review of epidemiologic evidence. Curr Atheroscler Rep 1999;1:204-9. View abstract.

Lima RPA, do Nascimento RAF, Luna RCP, et al. Effect of a diet containing folate and hazelnut oil capsule on the methylation level of the ADRB3 gene, lipid profile and oxidative stress in overweight or obese women. Clin Epigenetics 2017;9:110. View abstract.

Lutz M, Bonilla S, Concha J, et al. Effect of dietary oils, cholesterol and antioxidant vitamin supplementation on liver microsomal fluidity and xenobiotic-metabolizing enzymes in rats. Ann Nutr Metab 1998;42:350-9. View abstract.

Masthoff LJ, van Hoffen E, de Reus A, et al. Hazelnut allergy differs between children and adults in frequency of severity, aetiology and relevance of diagnostic parameters. Clin Exp Allergy 2014;44(12):1539-45. View abstract.

Masthoff LJ, van Hoffen E, Mattsson L, et al. Peanut allergy is common among hazelnut-sensitized subjects but is not primarily the result of IgE cross-reactivity. Allergy 2015;70(3):265-74. View abstract.

Munoz MF, Lopez-Cazana JM, Villas F, et al. Exercise-induced anaphylactic reaction to hazelnut. Allergy 1994;49:314-6. View abstract.

O'Mahony M, Mitchell E, Gilbert RJ, Hutchinson DN, et al. An outbreak of foodborne botulism associated with contaminated hazelnut yoghurt. (abstract) Epidemiol Infect 1990;104:389-95. View abstract.

Perna S, Giacosa A, Bonitta G, et al. Effects of hazelnut consumption on blood lipids and body weight: a systematic review and Bayesian meta-analysis. Nutrients 2016;8(12). pii: E747. View abstract.

Peroni DG, Dall'Agnola A, Piacentini GL, Boner AL. Worsening of atopic dermatitis by hazelnut essence contained in hydroxyzine syrup. Acta Paediatr 2007;96(11):1710. View abstract.

Pumphrey RS, Wilson PB, Faragher EB, Edwards SR. Specific immunoglobulin E to peanut, hazelnut and brazil nut 731 patients: similar patterns found at all ages. Clin Exp Allergy 1999;29:1256-9. View abstract.

Savage GP, McNeil DL. Chemical composition of hazelnuts (Corylus avellana) grown in New Zealand. Int J Food Sci Nutr 1998;49:199-203. View abstract.

Shahidi F, Alasalvar C, Liyana-Pathirana CM. Antioxidant phytochemicals in hazelnut kernel (Corylus avellana L.) and hazelnut byproducts. J Agric Food Chem. 2007 Feb 21;55(4):1212-20. View abstract.

Sutherland MF, O'Hehir RE, Czarny D, Suphioglu C. Macadamia nut anaphylaxis: demonstration of specific IgE reactivity and partial cross-reactivity with hazelnut. J Allergy Clin Immunol 1999;104:889-90.

Valcour A, Lidholm J, Borres MP, Hamilton RG. Sensitization profiles to hazelnut allergens across the United States. Ann Allergy Asthma Immunol 2019;122(1):111-6.e1. View abstract.

CONDITIONS OF USE AND IMPORTANT INFORMATION: This information is meant to supplement, not replace advice from your doctor or healthcare provider and is not meant to cover all possible uses, precautions, interactions or adverse effects. This information may not fit your specific health circumstances. Never delay or disregard seeking professional medical advice from your doctor or other qualified health care provider because of something you have read on WebMD. You should always speak with your doctor or health care professional before you start, stop, or change any prescribed part of your health care plan or treatment and to determine what course of therapy is right for you.

This copyrighted material is licensed from Therapeutic Research Center, LLC. Information from this source is evidence-based and objective, and without commercial influence. For professional medical information on natural medicines, see Natural Medicines Comprehensive Database Professional Version.
Licensed from Therapeutic Research Center, LLC
Copyright © 1995-2024 by Therapeutic Research Center, LLC. All Rights Reserved.